SLF
HALO icon

Sun Life Financial’s Halozyme HALO Stock Holding History

Sun Life Financial’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-383,173
Closed -$5.74M – 100
2013
Q4 		$5.74M Sell
383,173
-516,375
-57% -$6.64M 0.51% 55
2013
Q3 		$9.93M Sell
899,548
-52,160
-5% -$435K 0.89% 24
2013
Q2 		$7.56M Buy
+951,708
New +$6.06M 0.64% 38

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Sun Life Financial's HALO Position: Q1 2014 in Review

Sun Life Financial sold out of Halozyme (HALO) in Q1 2014, closing a stake of 383,173 shares — an estimated $5.74M sold.

Sun Life Financial first reported a position in HALO in Q2 2013 and held it in 3 quarters. The position peaked at $9.93M in Q3 2013. 131 funds tracked by Wall St. Rank hold HALO as of Q1 2014.

  • Sun Life Financial reported no remaining Halozyme position as of Q1 2014 after selling out during the quarter.
  • Sun Life Financial sold 383,173 Halozyme shares in Q1 2014, an estimated $5.74M.
  • Sun Life Financial first reported a position in Halozyme in Q2 2013 and held it in 3 quarters.
  • Sun Life Financial's Halozyme position peaked at $9.93M in Q3 2013.
  • 131 funds tracked by Wall St. Rank held Halozyme as of Q1 2014.

Based on Sun Life Financial's 13F filing for Q1 2014, filed 15 May 2014.